{
    "title": "110_s2470",
    "content": "The Act titled \"Dehydroepiandrosterone Abuse Reduction Act of 2007\" adds civil penalties for certain Dehydroepiandrosterone sales to the Controlled Substances Act. The \"Dehydroepiandrosterone Abuse Reduction Act of 2007\" prohibits the sale of products containing dehydroepiandrosterone to individuals under 18 years old, including online sales. Failure to check identification is considered knowing the individual's age. An affirmative defense is available for alleged violations. The Dehydroepiandrosterone Abuse Reduction Act of 2007 prohibits selling products containing dehydroepiandrosterone to individuals under 18 years old. An affirmative defense is available if the seller checked the purchaser's ID and reasonably concluded they were at least 18 years old. The Act does not apply to sales made with a valid prescription. The Attorney General can impose fines for violations, including those committed by employees or agents. The Dehydroepiandrosterone Abuse Reduction Act of 2007 imposes civil penalties for violations, with fines ranging from $1,000 to $5,000 based on the number of violations. Each location where sales occur is considered a separate entity for determining violations. The term \"identification card\" refers to an ID card used for age verification. The Dehydroepiandrosterone Abuse Reduction Act of 2007 defines an 'identification card' as a card with a photo and date of birth, issued by a State or Federal Government, and acceptable for age verification. The Act also requires the Attorney General to regulate Internet sales of dehydroepiandrosterone products within 180 days and imposes civil penalties for violations. The Attorney General must regulate Internet sales of dehydroepiandrosterone products within 180 days and impose civil penalties for violations. Regulations will include fines for retailers based on prior violations of the Controlled Substances Act. The Attorney General will regulate Internet sales of dehydroepiandrosterone products and impose fines on retailers for violations. Retailers may have fines reduced or eliminated based on effective employee training programs or other compliance actions. The term \"retailer\" includes grocery stores, general merchandise stores, drug stores, convenience stores, or similar entities. The Attorney General will regulate Internet sales of dehydroepiandrosterone products, imposing fines on retailers for violations. Retailers, including grocery stores, general merchandise stores, drug stores, convenience stores, or similar entities, may have fines reduced based on effective employee training programs or compliance actions. Drug stores, convenience stores, or other entities limited to personal use sales are exempt. The section on dehydroepiandrosterone sales supersedes any state laws related to its sale."
}